Radient Pharmaceuticals (RPC) Reports Q1 Loss of $0.13, Revenue Falls Y/Y
Tweet
Share
E-mailGet Alerts RPC Hot Sheet
Join SI Premium – FREE
Radient Pharmaceuticals (NYSE: RPC) reported Q1 EPS of ($0.13), versus ($0.10) reported last year. Revenue for the quarter came in at $30.66 million, versus $36.85 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
- Shoe Station Group Inc. (SHOE) Tops Q2 EPS by 11c ; Offers Guidance
- Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
